Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-9j3d9zPhase 2Recruiting
Phase 2, randomised, double-blind trial of budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Not reported. Started Jan 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-9j3d9z.